
    
      Children of Purpura nephritis with moderate protenuria(24 hours urinary protein quantitative
      0.5 ~ 1.0 1.73 g/m2 and 24 hours urinary protein amount of not more than 1.0 g) in this study
      was choosed as participatant, plan randomly into the group of 10 cases, treated with
      huaiqihuang particles and valsartan for 24 weeks to analyze the curative effect and clinical
      value of single drug therapy for children with purpura nephritis in reducing proteinuria,
      protecting renal function and promoting rehabilitation.
    
  